Study of the Potential Hepatoprotective Effect of Myo-Inositol and Its Influence on Zebrafish Development

Overview

Journal Nutrients

Date 2021 Oct 23

PMID 34684347

Citations 2

Authors

Tomasz Antonowski

Karol Wisniewski

Piotr Podlasz

Adam Osowski

Joanna Wojtkiewicz

Affiliations

Soon will be listed here.

Abstract

Inositol is a natural substance found widely in plants. It is used in therapies for many medical cases. The aim of this study was to determine the toxicity of myo-inositol (MI) and to investigate its potential hepatoprotective character. In the first part of the study, zebrafish embryos were incubated with 5, 10, 20, 40, 60, 80, and 100 mg/mL MI. Endpoints such as survivability, hatching rate, malformation, and mobility were evaluated. Our results demonstrated that the high doses of MI lead to increased mortality and malformations and reduce the hatching rate in comparison to the control group. Moreover, low doses of this compound do not produce a negative effect on zebrafish and even have the ability to increase the hatching rate and mobility. In the second part of the study, the hepatoprotective effect of MI was tested. Zebrafish larvae from the line Tg (fabp10a:DsRed) were incubated for 24 h with 1% and 2% ethanol (EtOH), 5 mg/mL of MI with 1% EtOH, and 5 mg/mL of MI with 2% EtOH. No significant differences between the groups with EtOH and the group treated with EtOH with MI were observed. Our results suggest that MI has no positive benefits on hepatocytes of zebrafish larvae.

Citing Articles

The Study of Myo-Inositol's Anxiolytic Activity on Zebrafish ().

Derkaczew M, Kedziora B, Potoczna M, Podlasz P, Wasowicz K, Jozwik M Nutrients. 2024; 16(13).

PMID: 38999746 PMC: 11243623. DOI: 10.3390/nu16131997.

Antiepileptic Properties of Scyllo-Inositol on Pentylenetetrazol-Induced Seizures.

Wisniewski K, Antonowski T, Juranek J, Podlasz P, Wojtkiewicz J Int J Mol Sci. 2023; 24(8).

PMID: 37108760 PMC: 10144795. DOI: 10.3390/ijms24087598.

References

Li J, Zhang Y, Liu K, He Q, Sun C, Han J . Xiaoaiping Induces Developmental Toxicity in Zebrafish Embryos Through Activation of ER Stress, Apoptosis and the Wnt Pathway. Front Pharmacol. 2018; 9:1250. PMC: 6233021. DOI: 10.3389/fphar.2018.01250. View

Unfer V, Facchinetti F, Orru B, Giordani B, Nestler J . Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017; 6(8):647-658. PMC: 5655679. DOI: 10.1530/EC-17-0243. View

Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S . Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Eur Rev Med Pharmacol Sci. 2011; 15(4):452-7. View

Howarth D, Passeri M, Sadler K . Drinks like a fish: using zebrafish to understand alcoholic liver disease. Alcohol Clin Exp Res. 2011; 35(5):826-9. PMC: 3083479. DOI: 10.1111/j.1530-0277.2010.01407.x. View

Wassink A, Olijhoek J, Visseren F . The metabolic syndrome: metabolic changes with vascular consequences. Eur J Clin Invest. 2006; 37(1):8-17. DOI: 10.1111/j.1365-2362.2007.01755.x. View

Maher J . Exploring alcohol's effects on liver function. Alcohol Health Res World. 1997; 21(1):5-12. PMC: 6826796. View

Passeri M, Cinaroglu A, Gao C, Sadler K . Hepatic steatosis in response to acute alcohol exposure in zebrafish requires sterol regulatory element binding protein activation. Hepatology. 2009; 49(2):443-52. PMC: 2635426. DOI: 10.1002/hep.22667. View

Shwartz A, Goessling W, Yin C . Macrophages in Zebrafish Models of Liver Diseases. Front Immunol. 2019; 10:2840. PMC: 6904306. DOI: 10.3389/fimmu.2019.02840. View

Selderslaghs I, Hooyberghs J, de Coen W, Witters H . Locomotor activity in zebrafish embryos: a new method to assess developmental neurotoxicity. Neurotoxicol Teratol. 2010; 32(4):460-71. DOI: 10.1016/j.ntt.2010.03.002. View

10.

Pak Y, Hong Y, Kim S, Piccariello T, Farese R, Larner J . In vivo chiro-inositol metabolism in the rat: a defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[3H]inositol into phospholipid in the Goto-Kakizaki (G.K) rat. Mol Cells. 1998; 8(3):301-9. View

11.

Osowski A, Kasparek A, Wieczorek Z, Amarowicz R, Szabelski M . Evaluation of the characteristics of some plant polyphenols as molecules intercepting mitoxantrone. Food Chem. 2017; 227:142-148. DOI: 10.1016/j.foodchem.2017.01.083. View

12.

Nordio M, Proietti E . The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. Eur Rev Med Pharmacol Sci. 2012; 16(5):575-81. View

13.

Martin K, Mani M, Mani A . New targets to treat obesity and the metabolic syndrome. Eur J Pharmacol. 2015; 763(Pt A):64-74. PMC: 4573317. DOI: 10.1016/j.ejphar.2015.03.093. View

14.

Dinicola S, Minini M, Unfer V, Verna R, Cucina A, Bizzarri M . Nutritional and Acquired Deficiencies in Inositol Bioavailability. Correlations with Metabolic Disorders. Int J Mol Sci. 2017; 18(10). PMC: 5666868. DOI: 10.3390/ijms18102187. View

15.

Choi M, Lee M, Jung U, Kim H, Do G, Park Y . Metabolic response of soy pinitol on lipid-lowering, antioxidant and hepatoprotective action in hamsters fed-high fat and high cholesterol diet. Mol Nutr Food Res. 2009; 53(6):751-9. DOI: 10.1002/mnfr.200800241. View

16.

Ostlund Jr R, McGill J, Herskowitz I, KIPNIS D, Santiago J, Sherman W . D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci U S A. 1993; 90(21):9988-92. PMC: 47698. DOI: 10.1073/pnas.90.21.9988. View

17.

Facchinetti F, Bizzarri M, Benvenga S, DAnna R, Lanzone A, Soulage C . Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS. Eur J Obstet Gynecol Reprod Biol. 2015; 195:72-76. DOI: 10.1016/j.ejogrb.2015.09.024. View

18.

Osowski A, Pietrzak M, Wieczorek Z, Wieczorek J . Natural compounds in the human diet and their ability to bind mutagens prevents DNA-mutagen intercalation. J Toxicol Environ Health A. 2010; 73(17-18):1141-9. DOI: 10.1080/15287394.2010.491044. View

19.

Osna N, Donohue Jr T, Kharbanda K . Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res. 2017; 38(2):147-161. PMC: 5513682. View

20.

Marrs J, Clendenon S, Ratcliffe D, Fielding S, Liu Q, Bosron W . Zebrafish fetal alcohol syndrome model: effects of ethanol are rescued by retinoic acid supplement. Alcohol. 2009; 44(7-8):707-15. PMC: 2889201. DOI: 10.1016/j.alcohol.2009.03.004. View